The American Journal of Bioethics · 2020 · 23 citations · 30 references
PharmacyPharmaceutical PolicyPharmacologyClinical PharmacologyClinical Trial RegulationDrug Approval ProcessesAccess To MedicinesClinical Trial Approval ProcessesClinical Trial AuthorizationClinical TrialsDisease Indication PrioritizationClinical Trial Access PolicyEmergency Access To MedicinesEmergency AuthorizationEmergency Treatment AuthorizationEquitable Access To Post-trial TreatmentEquitable Access To TrialsFairnessPrioritization
Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Authorization raises unique challenges at the intersection of clinical care and research. In conditions of scarcity, prioritization approaches should minimize harm, maximize benefit, and promote fairness. To promote continued data collection, patients seeking access to unproven COVID-19 drugs should receive lower priority for allocation when they decline to participate in clinical trials, either of the requested drug or other investigational products, offering a comparable balance of risks and benefits; special attention should be paid to concerns of voluntariness and distrust. In addition, institutional treatment protocols that can contribute more robust real world data should be preferred to single patient requests for access, with priority for inclusion based on traditional clinical allocation criteria relying on available evidence. Fairness demands distribution of these protocols across a diverse range of sites, particularly those serving marginalized populations, among other protections.
30
null · Philosophy study · 2016 · 28.3K citations · Full text
Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Ezekiel Emanuel, Govind Persad, Ross Upshur et al. · New England Journal of Medicine · 2020 · 3.2K citations
COVID-19 and Racial/Ethnic Disparities
Monica Webb Hooper, Anna María Nápoles, Eliseo J. Pérez‐Stable · JAMA · 2020 · 2.2K citations · Full text
COVID-19 and African Americans
Clyde W. Yancy · JAMA · 2020 · 2.1K citations